OA10669A - Zwitterionic forms of trovafloxacin - Google Patents

Zwitterionic forms of trovafloxacin Download PDF

Info

Publication number
OA10669A
OA10669A OA9800026A OA9800026A OA10669A OA 10669 A OA10669 A OA 10669A OA 9800026 A OA9800026 A OA 9800026A OA 9800026 A OA9800026 A OA 9800026A OA 10669 A OA10669 A OA 10669A
Authority
OA
OAPI
Prior art keywords
polymorph
compound
hygroscopic
pentahydrate
treating
Prior art date
Application number
OA9800026A
Other languages
English (en)
Inventor
Douglas John Meldrum Allen
David Bruning Joseph
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of OA10669A publication Critical patent/OA10669A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
OA9800026A 1995-08-29 1998-02-27 Zwitterionic forms of trovafloxacin OA10669A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
OA10669A true OA10669A (en) 2000-11-06

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9800026A OA10669A (en) 1995-08-29 1998-02-27 Zwitterionic forms of trovafloxacin

Country Status (30)

Country Link
EP (1) EP0850060A1 (ko)
JP (1) JP3188476B2 (ko)
KR (1) KR100343909B1 (ko)
CN (1) CN1190889A (ko)
AP (1) AP636A (ko)
AR (1) AR003985A1 (ko)
AU (1) AU704115B2 (ko)
BR (1) BR9609998A (ko)
CA (1) CA2229786C (ko)
CO (1) CO4480739A1 (ko)
CZ (1) CZ56698A3 (ko)
DZ (1) DZ2087A1 (ko)
GT (1) GT199600072A (ko)
HR (1) HRP960395B1 (ko)
HU (1) HUP9900170A3 (ko)
IL (1) IL122651A (ko)
MA (1) MA23966A1 (ko)
MY (1) MY113874A (ko)
NO (1) NO309814B1 (ko)
NZ (1) NZ312199A (ko)
OA (1) OA10669A (ko)
PE (1) PE12598A1 (ko)
PL (1) PL325170A1 (ko)
RU (1) RU2144921C1 (ko)
SK (1) SK23898A3 (ko)
TN (1) TNSN96109A1 (ko)
TR (1) TR199800339T1 (ko)
WO (1) WO1997007800A1 (ko)
YU (1) YU48396A (ko)
ZA (1) ZA967282B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
ZA967282B (en) 1998-03-02
JPH10511692A (ja) 1998-11-10
KR19990044232A (ko) 1999-06-25
MY113874A (en) 2002-06-29
EP0850060A1 (en) 1998-07-01
AU6367696A (en) 1997-03-19
IL122651A0 (en) 1998-08-16
JP3188476B2 (ja) 2001-07-16
CA2229786A1 (en) 1997-03-06
AR003985A1 (es) 1998-09-30
HUP9900170A3 (en) 1999-11-29
AP636A (en) 1998-04-09
AP9600853A0 (en) 1996-10-31
CO4480739A1 (es) 1997-07-09
NO980862D0 (no) 1998-02-27
MX9801664A (es) 1998-08-30
IL122651A (en) 2000-02-17
WO1997007800A1 (en) 1997-03-06
NO309814B1 (no) 2001-04-02
YU48396A (sh) 1998-12-23
BR9609998A (pt) 1999-07-06
TR199800339T1 (xx) 1998-06-22
PL325170A1 (en) 1998-07-06
NO980862L (no) 1998-02-27
TNSN96109A1 (fr) 2005-03-15
GT199600072A (es) 1998-02-14
PE12598A1 (es) 1998-03-20
KR100343909B1 (ko) 2003-04-10
MA23966A1 (fr) 1997-04-01
DZ2087A1 (fr) 2002-07-22
HUP9900170A2 (hu) 1999-05-28
HRP960395A2 (en) 1998-06-30
RU2144921C1 (ru) 2000-01-27
AU704115B2 (en) 1999-04-15
CA2229786C (en) 2002-02-19
HRP960395B1 (en) 2001-12-31
CN1190889A (zh) 1998-08-19
NZ312199A (en) 1999-06-29
CZ56698A3 (cs) 1999-02-17
SK23898A3 (en) 1999-05-07

Similar Documents

Publication Publication Date Title
US5763454A (en) Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
OA10669A (en) Zwitterionic forms of trovafloxacin
US6066647A (en) Zwitterionic forms of trovafloxacin
EP0266896B1 (en) 7-( (meta-substituted) phenylglycine) 1-carba-1-dethiacephalosporins
AU694149B2 (en) Process and intermediates for preparing naphthyridonecarboxylic acid salts
KR100274736B1 (ko) 6-엔-(엘-에이엘에이-엘-에이엘에이)-트로바플록사신 전구약물의 폴리모프
MXPA98001664A (en) Zwitterionic forms of trovafloxacin, procedure for its preparation, compositions that contain them and use of the mis
CA2258960C (en) A process for preparing naphthyridones and intermediates
US5331010A (en) 1-phenylalkanecarboxylic acid derivatives as anticonvulsant and neuroprotective agents
US5929240A (en) Process and intermediates for preparing naphthyridonecarboxylic acid salts
US6057455A (en) Preparation of intermediates useful in the synthesis of quinoline antibiotics
KR840002046B1 (ko) 세팔로스포린의 제조방법
RU2145323C1 (ru) Производные замещенных 1-(7-хлорхинолин-4-ил)пиразол-3-карбоксамид-n-оксидов, способ их получения, промежуточные соединения и фармацевтическая композиция
KR19980034828A (ko) 신규한 이소티아졸나프티리딘 유도체 및 그의 제조방법